Literature DB >> 25472800

Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation.

Nicoletta Riva, Marco P Donadini, Walter Ageno1.   

Abstract

Venous thromboembolism (VTE) is a multifactorial disease. Major provoking factors (e. g. surgery, cancer, major trauma, and immobilisation) are identified in 50-60 % of patients, while the remaining cases are classified as unprovoked. However, minor predisposing conditions may be detectable in these patients, possibly concurring to the pathophysiology of the disease, especially when co-existing. In recent years, the role of chronic inflammatory disorders, infectious diseases and traditional cardiovascular risk factors has been extensively investigated. Inflammation, with its underlying prothrombotic state, could be the potential link between these risk factors, as well as the explanation for the reported association between arterial and venous thromboembolic events.

Entities:  

Keywords:  Venous thromboembolism; atherothrombosis; etiopathogenesis; inflammation

Mesh:

Substances:

Year:  2014        PMID: 25472800     DOI: 10.1160/TH14-06-0563

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  30 in total

1.  Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Eur Respir J       Date:  2017-02-23       Impact factor: 16.671

2.  Increased systemic arterial stiffness in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Monika Sznajder; Olga Dzikowska-Diduch; Katarzyna Kurnicka; Marek Roik; Dominik Wretowski; Piotr Pruszczyk; Maciej Kostrubiec
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

Review 3.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

4.  Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.

Authors:  Magnus S Edvardsen; Kristian Hindberg; Ellen-Sofie Hansen; Vânia M Morelli; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; Line H Evensen; John-Bjarne Hansen
Journal:  Blood Adv       Date:  2021-01-12

Review 5.  Thrombosis in the setting of obesity or inflammatory bowel disease.

Authors:  Steven R Lentz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Epidemiology of venous thromboembolism in the Framingham Heart Study.

Authors:  Marja K Puurunen; Philimon N Gona; Martin G Larson; Joanne M Murabito; Jared W Magnani; Christopher J O'Donnell
Journal:  Thromb Res       Date:  2016-06-29       Impact factor: 3.944

7.  Direct oral anticoagulant treatment of deep vein thrombosis reduces IL-6 expression in peripheral mono-nuclear blood cells.

Authors:  Saverio Candido; Giovanni Lumera; Giuliana Barcellona; Davide Vetri; Elda Tumino; Ingrid Platania; Evelise Frazzetto; Graziella Privitera; Carmela Incognito; Agostino Gaudio; Salvatore Santo Signorelli
Journal:  Exp Ther Med       Date:  2020-10-21       Impact factor: 2.447

8.  Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease.

Authors:  Shyue-Luen Chang; Yau-Li Huang; Mei-Ching Lee; Sindy Hu; Yen-Chang Hsiao; Su-Wei Chang; Chee Jen Chang; Pei-Chun Chen
Journal:  JAMA       Date:  2018-02-27       Impact factor: 56.272

9.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

10.  Correlation study of venous thromboembolism with SAA, IL-1, and TNF-a levels and gene polymorphisms in Chinese population.

Authors:  Refukaiti Abuduhalike; Juan Sun; Li Zhao; Ailiman Mahemuti
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.